# Marc A. Pfeffer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marc-a-pfeffer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 145,600 |
| Field | Heart Failure Treatment and Management |
| h-index | 169 |
| i10-index | 552 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5031560506 |
| ORCID iD | 0000-0003-3876-7568 |
| Works | 871 |

## Researcher papers

Showing 12 of 45.

- [The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels](https://scholariq.org/papers/the-effect-of-pravastatin-on-coronary-events-after-myocardial-infarction-in/)
- [Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction](https://scholariq.org/papers/effect-of-captopril-on-mortality-and-morbidity-in-patients-with-left-ventricular/)
- [Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes](https://scholariq.org/papers/intensive-versus-moderate-lipid-lowering-with-statins-after-acute-coronary/)
- [Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events](https://scholariq.org/papers/cardiac-resynchronization-therapy-for-the-prevention-of-heart-failure-events/)
- [Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial](https://scholariq.org/papers/effects-of-candesartan-in-patients-with-chronic-heart-failure-and-preserved-left/)
- [Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.](https://scholariq.org/papers/ventricular-remodeling-after-myocardial-infarction-experimental-observations-and/)
- [Spironolactone for Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/spironolactone-for-heart-failure-with-preserved-ejection-fraction/)
- [Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial](https://scholariq.org/papers/effects-of-candesartan-in-patients-with-chronic-heart-failure-and-reduced-left/)
- [Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both](https://scholariq.org/papers/valsartan-captopril-or-both-in-myocardial-infarction-complicated-by-heart/)
- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome](https://scholariq.org/papers/lixisenatide-in-patients-with-type-2-diabetes-and-acute-coronary-syndrome/)
- [C-Reactive Protein Levels and Outcomes after Statin Therapy](https://scholariq.org/papers/c-reactive-protein-levels-and-outcomes-after-statin-therapy/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.